Derek E. Moore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Derek E. Moore has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
C. Wright Pinson
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
6 shared publicationsIrene D. Feurer
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
6 shared publicationsD. Lee Gorden
3 shared publicationsJ. Kelly Wright
3 shared publicationsClark D. Kensinger
Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA
2 shared publicationsDavid Shaffer
2 shared publications
Latest Publications
- 13 June 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (9) , 1036-1045
Patient‐reported outcomes in liver transplant recipients with hepatocellular carcinoma
Background: The effect of awarding MELD exception points for hepatocellular carcinoma (HCC) on patient‐reported outcomes (PROs) is unknown. We evaluated the physical and mental health‐related quality of life (HRQOL) and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC.Methods: The single‐center sample measured PROs before and after transplant, which included 1521 multisurvey measurement points among 502 adults (67% male, 28% HCC, follow‐up time: P=.016), a late decline in mental HRQOL, and delayed reduction in anxiety (time‐by‐outcome interaction P<.050) compared to patients with HCC who received exception points.Conclusion: Transplant recipients who received HCC exception points had PROs that were comparable to those of patients without HCC, and reported better physical HRQOL and reduced symptoms of anxiety compared to patients with HCC who did not receive exception points. These analyses demonstrate the impact of HCC exception points on PROs, and may help inform policy regarding HCC exception point allocation.
- 13 June 2016
- Published by Wiley in Clinical Transplantation
- Vol. 30 (9) , 1036-1045
Patient‐reported outcomes in liver transplant recipients with hepatocellular carcinoma
Background: The effect of awarding MELD exception points for hepatocellular carcinoma (HCC) on patient‐reported outcomes (PROs) is unknown. We evaluated the physical and mental health‐related quality of life (HRQOL) and symptoms of anxiety and depression in liver transplant recipients with HCC compared to patients without HCC.Methods: The single‐center sample measured PROs before and after transplant, which included 1521 multisurvey measurement points among 502 adults (67% male, 28% HCC, follow‐up time: P=.016), a late decline in mental HRQOL, and delayed reduction in anxiety (time‐by‐outcome interaction P<.050) compared to patients with HCC who received exception points.Conclusion: Transplant recipients who received HCC exception points had PROs that were comparable to those of patients without HCC, and reported better physical HRQOL and reduced symptoms of anxiety compared to patients with HCC who did not receive exception points. These analyses demonstrate the impact of HCC exception points on PROs, and may help inform policy regarding HCC exception point allocation.
- 1 November 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 199 (1) , 259-265
Multidisciplinary team approach to end-stage dialysis access patients
- 1 November 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 199 (1) , 259-265
Multidisciplinary team approach to end-stage dialysis access patients
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98 (1) , 88-93
Health Literacy of Living Kidney Donors and Kidney Transplant Recipients
Background Health literacy (HL) may be a mediator for known socioeconomic and racial disparities in living kidney donation. Methods We evaluated the associations of patient and demographic characteristics with HL in living kidney donors (LD), living donor kidney transplant recipients (LDR), and deceased donor recipients (DDR) in a single-center retrospective review of patients undergoing kidney donation or transplantation from September 2010 to July 2012. HL and demographic data were collected. HL was assessed via the Short Literacy Survey (SLS) comprising three self-reported screening questions scored using the five-point Likert scale (low [3–8], moderate [9–14], high [15]). Chi-square and logistic regression were used to test factors associated with lower HL. Results The sample included 360 adults (105 LD, 103 LDR, and 152 DDR; 46±14 years; 70% white; 56% male; 14±3 years of education). HL scores were skewed (49% high, 41% moderate, and 10% low). The distribution of HL categories differed significantly among groups (P=0.019). After controlling for age, race, sex, education, and a race-education interaction term, DDR was more likely to have moderate or low HL than LDR (OR, 1.911; 95%CI, 1.096–3.332; P=0.022). Conclusion Overall, living donors had high HL. The distribution of low, moderate, and high HL differed significantly between LD, DDR, and LDR. DDR had a higher likelihood of having low HL than LDR. Screening kidney transplant candidates and donors for lower HL may identify barriers to living donation. Future interventions addressing HL may be important to increase living donation and reduce disparities.
- 15 July 2014
- Published by Wolters Kluwer Health in Transplantation
- Vol. 98 (1) , 88-93
Health Literacy of Living Kidney Donors and Kidney Transplant Recipients
Background Health literacy (HL) may be a mediator for known socioeconomic and racial disparities in living kidney donation. Methods We evaluated the associations of patient and demographic characteristics with HL in living kidney donors (LD), living donor kidney transplant recipients (LDR), and deceased donor recipients (DDR) in a single-center retrospective review of patients undergoing kidney donation or transplantation from September 2010 to July 2012. HL and demographic data were collected. HL was assessed via the Short Literacy Survey (SLS) comprising three self-reported screening questions scored using the five-point Likert scale (low [3–8], moderate [9–14], high [15]). Chi-square and logistic regression were used to test factors associated with lower HL. Results The sample included 360 adults (105 LD, 103 LDR, and 152 DDR; 46±14 years; 70% white; 56% male; 14±3 years of education). HL scores were skewed (49% high, 41% moderate, and 10% low). The distribution of HL categories differed significantly among groups (P=0.019). After controlling for age, race, sex, education, and a race-education interaction term, DDR was more likely to have moderate or low HL than LDR (OR, 1.911; 95%CI, 1.096–3.332; P=0.022). Conclusion Overall, living donors had high HL. The distribution of low, moderate, and high HL differed significantly between LD, DDR, and LDR. DDR had a higher likelihood of having low HL than LDR. Screening kidney transplant candidates and donors for lower HL may identify barriers to living donation. Future interventions addressing HL may be important to increase living donation and reduce disparities.
- Open Access
- 25 August 2013
- Published by Frontiers Media SA in Transplant International
- Vol. 26 (11) , 1063-1069
Can donors with high donor risk indices be used cost-effectively in liver transplantation in US Transplant Centers?
In an effort to quantify the impact of donor risk factors on recipient outcomes, the donor risk index (DRI) was developed. A high DRI correlates with poorer post-transplant survival. In this study, high-DRI donors are classified as those having DRIs >2.0, while low-DRI donors have DRIs <2.0. The aim of this study was to evaluate the cost-effectiveness of high-DRI donor use in US Transplant Centers. A Markov-based decision analytic model was created to simulate outcomes for an allocation scheme using only low-DRI donors versus a scheme using both low- and high-DRI donors. Baseline values and ranges were determined from published data and Medicare cost data. Sensitivity analyses were conducted to test model strength and parameter variability. An allocation scheme in which only low-DRI donors were used generated 5.2 quality-adjusted life years (QALYs) at a cost of $83 000/QALY. An allocation scheme using both low- and high-DRI donors generated 5.9 QALYs at a cost of $66 000/QALY. Sensitivity analyses supported the use of an allocation scheme using both low- and high-DRI donors. The overall contribution of high-DRI grafts to the donor pool and the resultant reduction in wait-list mortality make them cost-effective.
- 25 August 2013
- Published by Frontiers Media SA in Transplant International
- Vol. 26 (11) , 1063-1069
Open AccessCan donors with high donor risk indices be used cost-effectively in liver transplantation in US Transplant Centers?
In an effort to quantify the impact of donor risk factors on recipient outcomes, the donor risk index (DRI) was developed. A high DRI correlates with poorer post-transplant survival. In this study, high-DRI donors are classified as those having DRIs >2.0, while low-DRI donors have DRIs <2.0. The aim of this study was to evaluate the cost-effectiveness of high-DRI donor use in US Transplant Centers. A Markov-based decision analytic model was created to simulate outcomes for an allocation scheme using only low-DRI donors versus a scheme using both low- and high-DRI donors. Baseline values and ranges were determined from published data and Medicare cost data. Sensitivity analyses were conducted to test model strength and parameter variability. An allocation scheme in which only low-DRI donors were used generated 5.2 quality-adjusted life years (QALYs) at a cost of $83 000/QALY. An allocation scheme using both low- and high-DRI donors generated 5.9 QALYs at a cost of $66 000/QALY. Sensitivity analyses supported the use of an allocation scheme using both low- and high-DRI donors. The overall contribution of high-DRI grafts to the donor pool and the resultant reduction in wait-list mortality make them cost-effective.
- 27 January 2013
- Published by Wiley in Clinical Transplantation
- Vol. 27 (2) , 289-296
More donors or more delayed graft function? A cost‐effectiveness analysis of DCD kidney transplantation
Expansion of the donor pool with expanded criteria donors and donation after cardiac death (DCD) donors is essential. DCD grafts result in increased rates of primary non‐function (PNF) and delayed graft function (DGF). However, long‐term patient and graft survival is similar between donation after brain death (DBD) donors and DCD donors. The aim of this study was to evaluate the cost‐effectiveness of the use of DCD donors. A Markov‐based decision analytic model was created to simulate outcomes for two wait list strategies: (i) wait list composed of only DBD organs and (ii) wait list combining DBD and DCD organs. Baseline values and ranges were determined from the Scientific Registry of Transplant Recipients (SRTR) database and literature review. Sensitivity analyses were conducted to test model strength and parameter variability. The wait list strategy consisting of DBD donors only provided recipients 5.4 Quality‐adjusted life years (QALYs) at $65 000/QALY, whereas a wait list strategy combining DBD + DCD donors provided recipients 6.0 QALYs at a cost of $56 000/QALY. Wait lists with DCD donors provide adequate long‐term survival despite more DGF. This equates to an improvement in quality of life and decreased cost when compared to remaining on dialysis for any period of time.
- 27 January 2013
- Published by Wiley in Clinical Transplantation
- Vol. 27 (2) , 289-296
More donors or more delayed graft function? A cost‐effectiveness analysis of DCD kidney transplantation
Expansion of the donor pool with expanded criteria donors and donation after cardiac death (DCD) donors is essential. DCD grafts result in increased rates of primary non‐function (PNF) and delayed graft function (DGF). However, long‐term patient and graft survival is similar between donation after brain death (DBD) donors and DCD donors. The aim of this study was to evaluate the cost‐effectiveness of the use of DCD donors. A Markov‐based decision analytic model was created to simulate outcomes for two wait list strategies: (i) wait list composed of only DBD organs and (ii) wait list combining DBD and DCD organs. Baseline values and ranges were determined from the Scientific Registry of Transplant Recipients (SRTR) database and literature review. Sensitivity analyses were conducted to test model strength and parameter variability. The wait list strategy consisting of DBD donors only provided recipients 5.4 Quality‐adjusted life years (QALYs) at $65 000/QALY, whereas a wait list strategy combining DBD + DCD donors provided recipients 6.0 QALYs at a cost of $56 000/QALY. Wait lists with DCD donors provide adequate long‐term survival despite more DGF. This equates to an improvement in quality of life and decreased cost when compared to remaining on dialysis for any period of time.
- Open Access
- 3 December 2012
- Published by Elsevier in American Journal of Transplantation
- Vol. 13 (2) , 450-457
A Web-Based Application for Initial Screening of Living Kidney Donors: Development, Implementation and Evaluation
- 3 December 2012
- Published by Elsevier in American Journal of Transplantation
- Vol. 13 (2) , 450-457
Open AccessA Web-Based Application for Initial Screening of Living Kidney Donors: Development, Implementation and Evaluation
- 1 March 2005
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 140 (3) , 273-277
Impact of Donor, Technical, and Recipient Risk Factors on Survival and Quality of Life After Liver Transplantation
Research from JAMA Surgery — Impact of Donor, Technical, and Recipient Risk Factors on Survival and Quality of Life After Liver Transplantation
- 1 March 2005
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 140 (3) , 273-277
Impact of Donor, Technical, and Recipient Risk Factors on Survival and Quality of Life After Liver Transplantation
Research from JAMA Surgery — Impact of Donor, Technical, and Recipient Risk Factors on Survival and Quality of Life After Liver Transplantation